6505--Lurasidone Tablets (VA-24-00084543)

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79724R0022
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) for an unrestricted procurement of Lurasidone Hydrochloride (HCL) Tablets. The contract will serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The VA will award a single contract to the responsible offeror who can provide an uninterrupted supply. The contract will be for one year with four one-year option periods. Offerors must provide a unique National Drug Code (NDC) number and label for the product. The solicitation will be issued electronically in commercial item format around August 2, 2024, with a tentative closing date of August 16, 2024. The NAICS code for this procurement is 325412.

There is no set-aside designation for this procurement. The estimated annual usage quantities range from 23,754 bottles for the 120mg strength to 59,189 bottles for the 40mg strength. No potential incumbents or current contractors are named, and the contract value is not specified.

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0022 for an unrestricted procurement for Lurasidone Hydrochloride (HCL) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.

All unit of use packaging identified in the Schedule of Supplies, (Line items 1 5, 30 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

Solicitation # 36E79724R0022 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 2, 2024, with a tentative closing date of August 16, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Ray Roldan. Questions can be emailed to Raymond.Roldan@va.gov.

The estimated annual requirements are as follows:Â Â

Â

REQUIREMENT DESCRIPTIONÂ

Item

Description

Package Size (Tablets per Bottle)

Total Estimated Annual Usage (Bottles)

1

LURASIDONE HCL 20MG TAB

30

46,838

2

LURASIDONE HCL 40MG TAB

30

59,189

3

LURASIDONE HCL 60MG TAB

30

30,646

4

LURASIDONE HCL 80MG TAB

30

55,649

5

LURASIDONE HCL 120MG TAB

30

23,754

Files

File Type Posted
36E79724R0022_1.docx DOCX document

Notice history

Notice Type Posted
6505--Lurasidone HCL Tablets Major Pharmaceuticals - 12/10/2024 - 12/9/2025 Award Award Notice
6505--Lurasidone Tablets (VA-24-00084543) Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity